Bio for Yi Tang, M. D.

Dr Yi Tang has been working in EPI team of WHO China office as a National Professional Officer for vaccine prequalification since April 2014.

When carrying out his duties in WHO China office, Dr Tang initiated the WHO prequalification advancing project for Chinese vaccines with direct support from WHO vaccine prequalification assessment team in WHO Headquarters; the project supported and facilitated preparing for and submitting WHO prequalification for vaccine products developed and manufacture from China during the past four years, this include investigation to potential Chinese vaccine candidates for WHO prequalification submission, strategic planning and technical roadmap defining with vaccine manufacturers for the candidate vaccines, coordinate and facilitate periodic technical consultation for the candidate vaccines with WHO vaccine prequalification assessment team, technical support to and also follow up with progress of the prequalification submission preparation, follow up and confirm technical commitments for prequalified vaccines, coordinate the communication and collaboration between WHO vaccine prequalification assessment team with China national regulatory authorities (NRA) on vaccine, information sharing with institutions and international organizations; Dr Tang was also involved in the technical collaboration between WHO and China NRA, coordinate and participate the strengthening of NRA functions in regulation of medical products including vaccines and standardization with international operations.

Before working in WHO China office, Dr Tang worked as a program officer in an international NGO Beijing office for 7 years, and was responsible for vaccine projects that collaborating with Chinese partners; one of his responsibilities was working in the project of SA 14-14-2 live attenuated Japanese Encephalitis vaccine which was the first WHO prequalified Chinese vaccine, manufactured by Chengdu Institute of Biological Products Company Limited (CDIBP) affiliated China National Biotech Group (CNBG) submitting WHO prequalification.

Dr Tang worked in several joint venture and local pharmaceutical companies for another 10 years before he worked in the NGO, he was in charge of the registration clinical studies and regulatory affairs.

Dr Tang graduated from Capital University of Medical Sciences in 1997 as a Medical Doctor in clinical Cardiology, before which time he studied in the same University for 11 years and graduated in 1991 for Medical Bachelor’s degree and 1994 for Medical Master’s degree in internal clinical medicine, respectively; Dr Tang has completed the five years full-time studying and training of both medical Master’s and Doctor’s degree in Beijing Chaoyang Hospital while working in the general internal department and department of cardiovascular diseases of the hospital as a physician.